JC virus (JCV) is a common human polyomavirus that infects 70 -80% of the population worldwide. In immunosuppressed individuals, JCV infects oligodendrocytes and causes a fatal demyelinating disease known as progressive multifocal leukoencephalopathy (PML). The tropism of JCV is restricted to oligodendrocytes, astrocytes, and B lymphocytes. Several mechanisms may contribute to the restricted tropism of JCV, including the presence or absence of cell-type-specific transcription and replication factors and the presence or absence of cell-type-specific receptors. We have established a system to investigate cellular factors that influence viral tropism by selecting JCV-resistant cells from a susceptible glial cell line (SVG-A). SVG-A cells were subjected to several rounds of viral infection using JC virus (M1/SVE⌬). A population of resistant cells emerged (SVGR2) that were refractory to infection with the Mad-4 strain of JCV, the hybrid virus M1/SVE⌬, as well as to the related polyomavirus SV40. SVGR2 cells were as susceptible as the SVG-A cells to infection with an unrelated amphotropic retrovirus. The stage at which these cells are resistant to infection was investigated and the block appears to be at early viral gene transcription. This system should ultimately allow us to identify glial specific factors that influence the tropism of JCV.
Introduction
JC virus is the causative agent of the fatal central nervous system (CNS) demyelinating disease progressive multifocal leukoencephalopathy (PML) that is due to JCV-induced lytic destruction of myelin-producing oligodendrocytes within the CNS. Although roughly 70 -80% of the worldwide population has been exposed to JCV, disease occurs only in immunocompromised individuals and approximately 4 -6% of AIDS patients develop PML (Hou and Major, 2000) . It is thought that immunosuppression can allow reactivation of latent virus which can spread to the CNS and infect oligodendrocytes (Lipton, 1991; Telenti et al., 1992; Tornatore et al., 1994) , and some have suggested that reactivation of latent virus within the CNS can contribute to the development of PML (Elsner and Dorries, 1992; Mori et al., 1991; Vago et al., 1996; White et al., 1992) .
JCV is a nonenveloped polyomavirus with doublestranded, circular DNA. The viral life cycle is temporally regulated with early gene expression occurring after the genome invades the nucleus of a cell. Early gene expression is followed by replication of the DNA and late gene expression. JCV is efficiently replicated only in glial cells. The reason for this restricted tropism is not understood, but may be due to the presence of cell-type-specific factors such as a receptor or transcription factors. Infection of glial cells has been shown to be dependent on the presence of an N-linked glycoprotein containing ␣(2-6)-linked sialic acid and its removal results in the amelioration of infection (Liu, Wei, and Atwood, 1998) . JCV virus-like particles (VLP) have been shown to bind other oligosacharrides (Komagome et al., 2002) and, although viral binding seems to correlate with susceptibility in primary cells (Wei, Liu, and Atwood, 2000) , the relationship between viral binding and cellular susceptibility is complicated by the many cell lines that bind virus but lack the ability to support infection (Suzuki et al., 2001 ). These data indicate that the presence of the correct receptor is not enough to render a cell permissive to JCV infection. The JCV promoter has been shown to be more active in glial cells than in cells of other lineages (Feigenbaum, Hinrichs, and Jay, 1992; Kenney et al., 1984; Raj and Khalili, 1995) , but this has not been proven to establish susceptibility. Active JC viral replication can be detected in oligodendrocytes, astrocytes, and B lymphocytes (Atwood et al., 1992; Major et al., 1992; Major et al., 1985; Sweet and Valle, 2002) but JCV DNA and early protein expression can be detected in a wider variety of cell types (Bendiksen et al., 2000; Dubois et al., 1997; Monaco et al., 1996; Ricciardiello et al., 2000) , suggesting that multiple factors are responsible for the tropism of the virus.
Despite significant progress in understanding transcriptional control of the JCV promoter in glial cells a glial specific factor that determines virus tropism has remained elusive (Chen and Khalili, 1995; Kerr et al., 1994; Lassak et al., 2002; Monaco et al., 2001; Raj et al., 1996; Ranganathan and Khalili, 1993) . This may be due to the lack of an efficient model for studying JCV tropism combined with the possibility that multiple factors are likely to be involved. We have established a system to investigate cellular factors that influence viral tropism by selecting JCV-resistant cells from a susceptible glial cell line (SVG-A). We infected SVG-A cells with JCV and established the resistant SVGR2 cell line by propagating cells that survived multiple rounds of lytic infection. The SVGR2 cell line proved to be resistant to infection by the Mad-4 strain of JCV, a chimeric JCV virus that contains elements of the SV40 promoter/enhancer region (M1/SVE⌬) (Vacante, Traub, and Major, 1989) , as well as to SV40. The resistant cells were, however, as susceptible as the parental cell line to infection by an unrelated retrovirus. We determined that the block to infection in SVGR2 cells is at the transcriptional level as the cells are also resistant to infection by viral DNA. Furthermore, both JCV and SV40 early promoter activity is significantly reduced in SVGR2 cells compared to SVG-A cells. The transcriptional block is specific for JCV and SV40 promoters as the cytomegalovirus (CMV) early promoter is unaffected. In addition the cells are susceptible to infection by an unrelated retrovirus. This novel cell line should allow us to establish which glial specific factors directly control JCV transcriptional activity. 
Results

SVGR2 cells are resistant to infection by JCV and SV40
To determine whether SVGR2 cells that survived multiple rounds of lytic infection with the M1/SVE⌬ virus were resistant to infection, we challenged them with both M1/ SVE⌬ and the Mad-4 strain of JCV. To assay for susceptibility to the virus, we used indirect immunofluorescence microscopy at three days postinfection to stain for the late viral protein V-antigen. Less than 1% of the surviving SVGR2 cells were susceptible to infection (Fig. 1C-F) . We also infected the cells with SV40 and found that infection was also significantly reduced in SVGR2 cells ( Fig. 1G and  H) . Since the M1/SVE⌬ virus used to derive the SVGR2 cells contains elements of the SV40 genome in its promoter, it is likely that we derived a cell line that is resistant to both viruses.
We next asked whether this resistance was specific to JCV and SV40 or if our approach had created a cell line that was nonspecifically resistant to viral infection. To investigate this, we used an unrelated, amphotropic retrovirus carrying the enhanced green fluorescent protein (EGFP) To ensure that we had not selected a subpopulation of nonglial cells from the original SVG-A glial cell line we stained both cell types with an antibody to the astrocyte specific marker glial fibrillary acidic protein (GFAP). Both SVG-A and SVGR2 cells expressed GFAP ( Fig. 2B and D), consistent with their astroglial lineage (Major et al., 1985) .
Viral binding is not reduced in SVGR2 cells
The cellular receptor for JCV is currently unknown, but it is thought to be an N-linked glycoprotein containing ␣(2-6)-linked sialic acids (Liu, Wei, and Atwood, 1998) . We reasoned that SVGR2 cells would be resistant to infection if they lacked a functional form of this receptor. Because we were unable to screen for the presence of the receptor directly, we compared the levels of virus binding between the resistant cells and the susceptible parental cell line. FITC-labeled M1/SVE⌬ was diluted in PBS and added to SVG-A and SVGR2 cells. The level of virus binding was determined by mean fluorescence intensity (MFI) using flow cytometry. The MFI of untreated SVG-A cells was used as a control and all samples were gated on live cells. The level of virus binding to each cell type was equivalent (Fig. 3) . Because there was no significant difference in virus binding between the cell types, we concluded that the block to infection of SVGR2 cells occurs after the initial viruscell interaction.
SVGR2 cells are resistant to infection by viral DNA
To investigate whether SVGR2 cells were resistant to infection with viral DNA we transfected both SVG-A and SVGR2 cells with DNA isolated from M1/SVE⌬ virions. V-antigen (V Ag) expression was then scored at 3 days posttransfection by indirect immunofluorescence microscopy. SVGR2 cells remained refractory to infection with viral DNA indicating that the block to infection was downstream of receptor binding and entry (Fig. 4A , panels b and d). A cytomegalovirus (CMV)-␤gal reporter plasmid was used to control for transfection efficiency. At 48 h posttransfection ␤-galactosidase-expressing cells were scored by counting blue cells. ␤-Galactosidase expression was slightly reduced in SVGR2 cells compared to SVG-A cells. To ensure that this reduced expression of the reporter gene was not due to a defect in CMV promoter activity, the transfection efficiencies of both cell lines were confirmed using a Southern blot to compare levels of transfected DNA (data not shown). We found the transfection efficiency of SVGR2 to be reduced approximately 2.5-fold compared to SVG-A cells using both methods. We then used this number to normalize for transfection efficiencies and found that SVGR2 cells were still resistant to infection by JCV DNA compared to SVG-A cells (Fig. 3B) .
To further show that the block to infection of SVGR2 cells was transcriptional we used a chloramphenicol acetyltransferase (CAT) reporter gene assay. SVG-A and SVGR2 cells were transfected with pM1CAT and pSV2CAT DNA. The pM1CAT reporter construct produces chloramphenicol acetyltransferase under the control of the Mad-1 JCV early promoter as previously described (Atwood et al., 1995) . The pSV2CAT reporter construct is driven by the SV40 early promoter. The activity of each promoter was determined by harvesting equal amounts of protein from the cells and testing for CAT activity over time. Transfection efficiencies were controlled for with the CMV-␤gal assay. The activity of pM1CAT was reduced 2.3-fold and pSV2CAT activity was reduced 7.7-fold (Fig. 5) . Taken together, these data clearly show that there is a defect in JCV and SV40 viral transcription that does not extend to CMV or retroviral gene transcription.
Although promoter activity was reduced in SVGR2 cells, the transfection experiments indicated that SVGR2 cells did support a small amount of basal promoter activity. We considered the possibility that this low level of activity could be enough to allow viral transcription to occur and that there might be a complete block to translation. In order to determine if this were the case, we infected the SVG-A and SVGR2 cell lines with M1/SVE⌬. At 2 and 3 days postinfection, we harvested RNA from these cells and reverse transcribed it into cDNA. We then used either JCV T-antigen-or V-antigenspecific primers to amplify the early and late viral gene transcripts. Early viral gene transcription was undetectable in SVGR2 cells (Fig. 6A , lane 5) at polymerase chain reaction (PCR) conditions that were sufficient to reveal transcription in the parental cell line (Fig. 6A, lane 1) . The late viral transcript was also undetectable in infected SVGR2 cells (Fig. 6B , lane 7), whereas it was easily detected by PCR in the susceptible SVG-A cell line (Fig. 6B , lane 5). To confirm that each reaction contained the same amount of starting material, we performed control experiments using GAPDH specific primers.
To ensure that we were not amplifying input viral DNA, we set up reactions lacking reverse transcriptase as negative controls. The fact that viral transcripts were not made in resistant, infected cells led us to surmise that the block to infection must occur prior to this step in the viral life cycle. Our data indicate that the SVGR2 cell line is resistant to JCV infection due to a deficit in viral gene transcription, not translation.
Resistant cells do not harbor latent virus
We next investigated whether our method of using JCV to select for resistant cells had caused the cells to become doubly transformed. Since there have been cases where a preexisting viral infection prevents subsequent infection by other viruses through various mechanisms of viral interference (Potash and Volsky, 1998; VandeWoude et al., 2002) , we wanted to ensure that a second transformation event by JCV T-Ag was not preventing the SVGR2 cells from becoming infected. To investigate whether SVGR2 cells harbored a latent JCV genome, PCR was carried out using JCV T-antigen-specific primers on SVG-A and SVGR2 cells, as well as three subclones of each (Fig. 7) . The positive control reaction was performed on 10 pg of JCV DNA. Uninfected SVG-A cells were negative because the primers do not cross-react with the SV40 T Ag used to initially transform the SVG-A cell line. Low levels of JCV T-antigen DNA were detected in the SVGR2 genome. This may be caused by the presence of residual surviving cells that are susceptible to JCV, or alternately, the resistance of some of the cells could have been due to their transformation by JCV T-Ag. We assumed that this was due to the fact that the SVGR2 cell line was created from a pool of resistant cells. This ambiguity was eliminated after the cells were subcloned. All three subclones derived from SVGR2 cells were entirely resistant to infection and were completely devoid of JCV DNA, indicating that they are not latently infected with the virus. This suggests that the cells are indeed resistant to infection and that it is not merely superinfection or double transformation that prevents JCV gene expression.
Discussion
The SVGR2 cell line was derived directly from the JCV-sensitive SVG-A cell line and is resistant to infection by JCV and SV40. SVGR2 cells are not, however, resistant to infection by all viruses as revealed by infection with an Fig. 6 . RT-PCR experiments show that viral genes are not transcribed in SVGR2 cells. RNA was isolated from cells that were uninfected or infected using M1/SVE⌬. After reverse transcription, (A) T-antigen or (B) Vantigen specific primers were used to amplify JCV transcripts. GAPDHspecific primers were used as a positive control and reverse transcriptase was omitted as a negative control. (A) SVG-A cells infected with and without reverse transcriptase (RT) (lanes 1 and 2), SVG-A uninfected cells with and without RT (lanes 3 and 4), SVGR2 infected with and without RT (lanes 5 and 6), SVGR2 uninfected with and without RT (lanes 7 and 8), and no-template negative controls with and without RT (lanes 9 and 10). (B) SVG-A uninfected with and without RT (lanes 1 and 2), SVGR2 uninfected with and without RT (lanes 3 and 4), SVG-A infected with and without (RT) (lanes 5 and 6), and SVGR2 infected with and without RT (lanes 7 and 8). Viral transcription was undetectable after SVGR2 cells were infected with M1/SVE⌬, indicating that these cells are resistant to the virus at a point after viral binding, but prior to early viral gene transcription.
EGFP-expressing retrovirus. Equal expression of the astrocyte intermediate filament marker GFAP in both cell lines indicates that SVGR2 cells still retain astroglial characteristics. These data suggest that the SVGR2 cell line is different from the parental line in a way that is crucial to the life cycle of JC virus. We attempted to characterize this difference by comparing viral binding, infection, and viral gene expression between the two cell lines. We have shown that SVGR2 cells are resistant to infection by the Mad-4 strain of JCV, a chimeric JC/SV40 virus, and SV40 but are permissive for the unrelated EGFP-expressing retrovirus. Furthermore, we have directly shown that viral transcription from the JCV and SV40 early promoters is reduced in SVGR2 cells, although transcription from another DNA viral promoter (CMV) is not reduced. The results of our experiments suggest that SVGR2 cells are resistant to JCV because they do not support the generation of viral transcripts. As SVGR2 cells were derived from a virus containing portions of both the SV40 and JCV promoters, and they are resistant to both JCV and SV40, it is likely that this resistance is due to a block at viral transcription.
This approach has allowed us to derive a cell line that is resistant to infection by a virus that is tropic for the parental cell line. The fact that these two cell lines are closely related, yet differ in their susceptibility to viral infection, suggests that the adaptation that occurred in the resistant cell line must be directly influencing infection. One possibility is that we eliminated a population of cells that was susceptible to JCV infection and the surviving cells consist of a subpopulation that was naturally resistant. The similarities between the cell lines will prove crucial in the search of the reason for the resistance to infection of the derived cell line. Techniques such as cDNA array analysis and subtractive hybridization rely on the ability to discern between random variation and biologically important differences. Library screening should also be simplified since it is more likely that there is only a single factor different between the two cell lines responsible for the resistance to infection. The results of these screens will inevitably prove more useful if the stage of viral resistance is determined prior to screening for differences.
One cellular factor that has been shown to limit viral tropism is the restricted expression of a specific receptor that allows viral entry (Bai, Harfe, and Freimuth, 1993; Dalgliesh et al., 1984; Haun et al., 1993; Haywood, 1994) . Others have shown that presence of a viral receptor may not be sufficient to guarantee productive infection (Atwood and Norkin, 1989; Bass and Greenberg, 1992; Mei and Wadell, 1995) . Many other host factors interact with the viral regulatory proteins during the life cycle, and the neurotropism of JCV has been attributed to its early promoter (Raj and Khalili, 1995) . Although no factors required for JCV infection have yet been shown to be glial specific, the expression of some necessary transcription factors are upregulated in the brain. Sequence analysis has implicated that the different classes of nuclear factor-1 (NF-1) interact with the JCV promoter (Tamura et al., 1988) . NF-1 class D has been shown to be upregulated in the brain compared to the other classes (Sumner et al., 1996) , and recently it has been shown to play a role in JC virus multiplication (Monaco et al., 2001 ). Since it is expressed in many different cell types, it is likely that this factor is only partially responsible for the tropism of the virus. It is also likely that the regulatory region sequences of JCV limit viral expression to certain cell types (Daniel et al., 1996; Liu et al., 1997) , and different arrangements within this region may influence the tropism of JCV. For these reasons, the combinations of transcription factors and negative regulatory factors that are present within a cell may be the most important determinants in the tropism of JCV. This approach will allow us to compare a susceptible glial cell to a resistant glial cell and should allow us to elucidate a glial specific factor that determines JCV tropism. Another benefit is that this approach can be used repeatedly to study different aspects of the same virus. It should be possible to derive several cell lines that are resistant for different reasons using this system. These resistant lines should provide models to ascertain different factors that are involved in the viral life cycle. These data could then be compiled to provide an understanding of the underlying factors behind JCV tropism. It may also give insight into the mechanism that allows disease to occur in only a small fraction of infected individuals.
Materials and methods
Cells and virus
The SVG-A cell line was subcloned from the original SVG cell line established by transformation of human fetal glial cells by an origin-defective SV40 mutant (Major et al., 1985). The SVGR2 cell line was derived from SVG-A cells that survived multiple rounds of infection with the M1/ SVE⌬ virus. Several subclones were established from each cell line by limited-dilution cloning. The cells were maintained in humidified 37°C CO 2 incubators in Eagle's minimum essential medium (EMEM) supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. The laboratory strain of virus used was M1/SVE⌬ and the wildtype strains used were JCV (Mad-4) and SV40 (776).
Indirect immunofluorescent assays
Cells grown on coverslips were infected for 1 h with Mad-4 or M1/SVE⌬ JCV at a multiplicity of infection (MOI) of 8.7 ϫ 10 4 or with SV40 at a MOI of 45 in the presence of EMEM plus 2% serum in a total volume of 100 l. At 3 days postinfection, coverslips were washed in PBS and fixed for 10 min in acetone. The cells were incubated with either the anti-V-antigen monoclonal antibody PAB597 (undiluted hybridoma supernatant) or anti-T-antigen antibody diluted 1:100 in PBS for 45 min at 37°C. Cells were then washed three times with PBS and incubated with a FITC-labeled goat antimouse secondary antibody for 45 min at 37°C. Cells were again washed three times with PBS, counterstained with PBS containing 0.02% Evans blue, and washed again in PBS. Coverslips were mounted on slides and visualized on a Zeiss epifluorescence microscope and images were captured by a digital camera.
GFAP expression was detected in acetone fixed cells grown on glass coverslips using a mouse monoclonal antibody against human GFAP (Sigma) to detect the astrocytespecific intermediate filament protein. A goat antimouse Alexaflour 488 secondary antibody was used to visualize the protein. Nuclei were visualized with a propidium iodine based mounting medium (Vector).
Transfection efficiency
SVG-A and SVGR2 cells were transfected with 1 g plasmid DNA containing the ␤-galactosidase gene driven by the cytomegalovirus (CMV) promoter (pCMV␤-gal) by standard CaPO 4 transfection methods. Transfection efficiency was determined using a ␤-galactosidase reporter gene staining kit (Sigma) to calculate a normalization factor for further studies.
CAT assay
The CAT reporter plasmids pSV2CAT and pM1CAT were introduced into each cell line by CaPO 4 -mediated transfection. Each experiment was done in triplicate and control experiments were also done with no DNA. Fortyeight hours after transfection, cells were washed two times in PBS, harvested by scraping, and lysed by three successive freeze-thaw cycles. Cell debris was removed by centrifugation and the protein concentration of the cell extract was determined by the Bradford method (Bradford, 1976) . Equivalent amounts of protein were assayed for CAT activity with the fluor diffusion method described by Neuman (Neuman, Morency, and Russian, 1987 ) and recorded over 3 h with a Beckman ␤-counter.
Infection with retrovirus
Packaging cells were transfected with plasmid DNA carrying the enhanced green fluorescent protein (EGFP) gene overnight in media containing 25 M chloroquine using standard CaPO 4 transfection techniques. Medium containing 25 M chloroquine was removed and replaced with DMEM 16 h after it was added. Supernatant containing amphotropic retrovirus was harvested at 72 h posttransfection. The retrovirus was purified by centrifugation or filtration and used immediately or, alternately, frozen at Ϫ80°C. SVG-A and SVGR2 cells were transduced with retrovirus diluted 50% with EMEM in the presence of 2 g/ml polybrene for 5 h.
Virus binding assays
For virus binding assays, cells were removed from tissue culture dishes by incubation with Versene and resuspended in PBS at 10 5 cells/ml. The cells were incubated on ice either with increasing concentrations of FITC-labeled JCV virions or without virus as a negative control. After a 30-min incubation, cells were washed once in PBS containing 0.05 mg of propidium iodide/ml, washed twice in PBS, and resuspended in PBS. The cells were immediately analyzed on a Beckton-Dickenson FACScalibur flow cytometer. Data gated on live cells was gathered using CellQuest™ software.
PCR and RT-PCR
For JCV T-antigen detection, DNA was isolated from SVG-A and SVGR2 cells, as well as from three subclones of each cell line, using standard phenol/chloroform extraction. The JCV T-antigen-specific primer sequences were 5Ј-GAATAGGGGAGGAATCCATGG-3Ј and 5Ј-GGAAT-GCATGCAGATCTACAGG-3Ј. Amplification was carried out on 500 ng of template DNA in a total volume of 20 l. The PCR program comprised of 35 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 2 min. Samples amplified from JCV DNA served as a positive control. Bands were visualized by separation of samples on a 1% TAE agarose gel and visualized by staining with ethidium bromide.
For RT-PCR, total RNA was harvested from SVG-A and SVGR2 cells 3 days postinfection with M1/SVE⌬ JCV at an MOI of 8.7 ϫ 10 4 using the S.N.A.P. Total RNA Isolation kit (Invitrogen). Reverse transcription was performed for T-antigen and V-antigen on 500 ng of total RNA using the Access RT-PCR system (Promega) according to the man-ufacturer's instructions. The primers were JCV V-antigen specific: (upstream) JCV1991-2020 5Ј-GCCACAGTG-CAATCTCAAGTCATGAACACA-3Ј and (downstream) JCV 2139-2121 5Ј-GGAACATTTTCTCCTCCTG-3Ј. The PCR reaction was carried out for 30 cycles with a denaturing step of 94°C for 30 s, annealing at 60°C for 60 s, and an elongation step at 68°C for 2 min. This was followed by a 7-min final elongation step at 68°C. Samples were separated on a 5% polyacrylamide gel and visualized by ethidium bromide staining under UV light. A positive control reaction was performed using glyceraldehyde-3-phosphate dehydrogenase-(GAPDH) specific primers and negative control reactions were carried out without reverse transcriptase.
